Neuromodulation has revolutionized the treatment of movement disorders such as Parkinson’s disease, dystonia, and essential tremor. With advancements in ...

Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for ...

Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirementNEWTOWN, ...

Maryam, a twelve-year-old from Yemen, suffered from a congenital spinal defect. She received treatment at Inamdar ...

A Dutch neuromodulation developer has raised $60 million to complete the development of its minimally invasive implant for ...

Abstract: Continuous sacral neuromodulation (SNM) is used to treat overactive bladder, reducing urine leakage and increasing capacity. Conditional SNM applies stimulation in response to changing ...

A Breakthrough Botanical Formula Backed by 2025 Nobel Research Offers Lasting Relief from Ear Ringing and Auditory Imbalance ...

ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the ...

Vivani Medical, Inc. VANI recently announced the filing of a Form 10 registration statement with the U.S. Securities and ...

Investor capital is pouring into AI-driven healthcare, with Pittsburgh-based Abridge AI Inc. pulling in $300 million at a ...

A breakthrough nerve therapy is improving stroke survivors' mobility and quality of life. A UConn doctor is asking the state ...

Helius Medical Technologies ( ($HSDT) ) just unveiled an update. On June 3, 2025, Helius Medical Technologies received formal notification from ...